001     152992
005     20240229120021.0
024 7 _ |a 10.1186/s13058-019-1231-z
|2 doi
024 7 _ |a 1465-5411
|2 ISSN
024 7 _ |a 1465-542X
|2 ISSN
024 7 _ |a altmetric:72730371
|2 altmetric
024 7 _ |a pmid:31829264
|2 pmid
037 _ _ |a DKFZ-2020-00089
082 _ _ |a 610
100 1 _ |a Sinn, Bruno Valentin
|0 0000-0002-1257-9799
|b 0
245 _ _ |a Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy
260 _ _ |a London
|c 2019
|b BioMed Central
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1578475895_27265
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 899 - ohne Topic (POF3-899)
|0 G:(DE-HGF)POF3-899
|c POF3-899
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Weber, Karsten E.
|b 1
700 1 _ |a Schmitt, Wolfgang Daniel
|b 2
700 1 _ |a Fasching, Peter A.
|b 3
700 1 _ |a Symmans, William Fraser
|b 4
700 1 _ |a Blohmer, Jens-Uwe
|b 5
700 1 _ |a Karn, Thomas
|b 6
700 1 _ |a Taube, Eliane Tabea
|b 7
700 1 _ |a Klauschen, Frederick
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Marmé, Frederik
|b 9
700 1 _ |a Schem, Christian
|b 10
700 1 _ |a Stickeler, Elmar
|b 11
700 1 _ |a Ataseven, Beyhan
|b 12
700 1 _ |a Huober, Jens
|b 13
700 1 _ |a von Minckwitz, Gunter
|b 14
700 1 _ |a Seliger, Barbara
|b 15
700 1 _ |a Denkert, Carsten
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Loibl, Sibylle
|b 17
773 _ _ |a 10.1186/s13058-019-1231-z
|g Vol. 21, no. 1, p. 142
|0 PERI:(DE-600)2041618-0
|n 1
|p 142
|t Breast cancer research
|v 21
|y 2019
|x 1465-542X
909 C O |o oai:inrepo02.dkfz.de:152992
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF3-890
|0 G:(DE-HGF)POF3-899
|2 G:(DE-HGF)POF3-800
|v ohne Topic
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BREAST CANCER RES : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b BREAST CANCER RES : 2017
920 1 _ |0 I:(DE-He78)L201-20160331
|k L201
|l DKTK Berlin
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)L201-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21